Drug resistance profile of Mycobacterium tuberculosis in China: update until 2024
Our analysis demonstrates that drug-resistant tuberculosis remains a serious challenge in China. Newly identified resistance-conferring mutations should be prioritized and integrated with the specific epidemiological characteristics of DR-TB in China to support the development and implementation of rapid diagnostic technologies.
Authors
- Jianxiong Lin (ORCID: https://orcid.org/0000-0001-5778-6284)
- Qiao‐Cheng Chang (ORCID: https://orcid.org/0000-0002-9322-6142)
- Sixuan Liu (ORCID: https://orcid.org/0000-0003-0070-9194)
- Yannan Xu
- Jiana Zheng (ORCID: https://orcid.org/0009-0000-6424-9751)
- Liwei Gi
Institutions
- Jinan University (CN)
- Jilin University (CN)
- Shantou University (CN)
Publication Details
- Journal
- Frontiers in Microbiology
- Published
- 2025-12-09
- DOI
- https://doi.org/10.3389/fmicb.2025.1697490
- Citations
- 1
- Primary Topic
- Tuberculosis Research and Epidemiology
- Type
- article
- Field-Weighted Citation Impact
- 1.40